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A 31 year old woman who developed an atypical ven· 
tricular tachycardia after administration of intravenous 
verapamil for control of a recurrent supraventricular 
tachycardia is presented. Possible explanations for the 
observed arrhythmia, polymorphous ventricular tachy· 
Intravenous verapamil administration is a well recognized 
means of terminating paroxysmal supraventricular tachyar-
rhythmias (1). However, deleterious effects can occur in 
patients with poor left ventricular function secondary to the 
drug's negative inotropic and hypotensive effects. This re-
port describes another potential complication of intravenous 
verapamil administration, polymorphous ventricular tachy-
cardia, during the conversion of paroxysmal supraventric-
ular tachycardia to sinus rhythm. 
Case Report 
The patient was a 31 year old woman with a history of 
supraventricular arrhythmias since childhood. Prophylaxis 
with digitalis, beta-adrenergic blocking agents and various 
type I antiarrhythmic agents had been unsuccessful in con-
trolling recurrent episodes. One year before hospital ad-
mission, the patient presented to this medical center with 
paroxysmal supraventricular tachycardia. No pre-excitation 
pattern was seen on electrocardiograms at rest or 24 hour 
continuous ambulatory monitoring. She had no structural 
heart disease and electrophysiologic testing revealed an 
atrioventricular (A V) nodal reentrant tachycardia, the in-
duction of which was prevented by intravenous verapamil. 
The patient was maintained on a regimen of 120 mg 
verapamil (lsoptin) orally, three times daily. Three days 
before admission, her prescription was refilled with the CaJan 
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cardia, are discussed. Verapamil must be considered one 
of the pharmacologic agents that can cause this 
arrhythmia. 
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brand of verapamil. Concerned that she might have received 
the wrong medicine, she did not take any verapamil over 
the following 3 days. She subsequently had an onset of 
rapid heartbeats and presented to the emergency room with 
profound light-headedness and diaphoresis. The electrocar-
diogram (Fig. 1) revealed a regular, narrow complex tachy-
cardia, at a rate of 150 beats/min, without discernible P 
waves. The systolic blood pressure was 70 mm Hg with the 
cuff method, and no diastolic pressure could be measured. 
Five milligrams of intravenous verapamil were administered 
slowly, and while she noted an irregularity to her palpitation, 
the rhythm in Figure 2 was recorded and lasted for approx-
imately 30 seconds. The tracing revealed an atypical ven-
tricular tachycardia, with varying QRS configuration rotat-
ing around a stable baseline, interspersed with sinus rhythm. 
The rhythm then converted to sinus tachycardia at a rate of 
110 beats/min (Fig. 3). The patient was observed overnight 
and discharged taking her previous medication. 
Discussion 
Mechanism. In this young woman, AV nodal reentrant 
tachycardia transiently progressed to an irregular, wide com-
plex tachycardia with varying QRS configuration in re-
sponse to intravenous verapamil. The two possible causes 
of this tachyarrhythmia include atrial fibrillation with aber-
rancy and polymorphous ventricular tachycardia. The for-
mer is unlikely because 1) a premature ventricular complex 
initiated the arrhythmia; 2) the baseline was isoelectric; 3) 
the wide QRS complexes show marked variation and did 
not reveal classic aberrant right or left bundle branch block 
patterns; and 4) intermittent sinus beats with fusion com-
plexes were present (Fig. 2). Furthermore, termination of 
supraventricular tachycardia has been associated with wide 
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Figure 1. Electrocardiogram recorded on presen-
tation to the emergency room, revealing a supra-






QRS rhythms that are ventricular in origin. Conversion ar-
rhythmias, including premature ventricular complexes and 
short runs of nonsustained ventricular tachycardia, have been 
associated with the use of intravenous verapamil for therapy 
of supraventricular tachycardia (2,3). The transition rhythm 
in our case represents polymorphous ventricular tachycar-
dia. As is characteristic, the rhythm is an atypical form of 
ventricular tachycardia with QRS complexes of varying am-
plitudes that rotate around the baseline (4-6). 
Etiology. Polymorphous ventricular tachycardia of this 
duration has not previously been reported to occur as a 
conversion rhythm in patients with supraventricular tachy-
cardias acutely treated with verapamil. Such rhythms are 
associated with long-term antiarrhythmic therapy with quin-
idine, procainamide and disopyramide (4-6). Bradycardia, 
autonomic dysfunction, electrolyte imbalances, phenothi-
azine use and myocardial ischemia can also result in epi-
sodes of polymorphous ventricular tachycardia (4-6). Usu-
ally, such rhythm disturbances are associated with prolonged 
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Figure 2. Electrocardiographic rhythm strips recorded at time of 
administration of intravenous verapamil, revealing periods of atyp-
ical ventricular tachycardia with QRS complexes rotating around 
the baseline. 
Figure 3. Electrocardiogram recorded after con-
version to sinus rhythm. 
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repolarization, detected as a lengthened corrected QT (QTJ 
interval on surface electrocardiogram (4-6). However, in 
our patient the serum electrolytes were normal, none of the 
other preceding conditions was suspected and there was no 
observed QTc prolongation before the onset of the conver-
sion arrhythmia. 
The cause of verapamil-induced ventricular arrhythmias 
is unclear. Interference with the inward calcium current 
disturbs A V nodal conduction, permitting reentrant rhythms 
to cease (l). Simultaneously, verapamil induces a cate-
cholamine surge, in part because of its hypotensive effects. 
Thus, a high state of adrenergic tone could have resulted in 
triggered forms of automaticity and caused the particular 
arrhythmia. Myocardial ischemia due to profound hypoten-
sion may cause the arrhythmia; however, the absence of 
chest pain or ischemic changes on the electrocardiogram 
makes this possibility unlikely. 
In conclusion, we report a case of polymorphous ven-
tricular tachycardia, requiring no intervention, during con-
version from an A V nodal reentrant tachycardia to sinus 
rhythm with intravenous verapamil administration. The rhythm 
observed was well tolerated and terminated spontaneousl y. 
However, in patients with compromised left ventricular 
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function, such an arrhythmia could prove deleterious and 
require further intervention. Cautious monitoring is essential 
when administering verapamil to treat supraventricular 
arrhythmias. 
We gratefully thank Valentin Fuster. MD for his encouragement and sup-
port and Millie Tolson for secretarial assistance. 
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